Olivier Muller*
The global population is aging rapidly, and the number of octogenarians is steadily increasing. With aging, the risk of cardiovascular diseases also rises. As a result, many octogenarians require multiple medications to manage their cardiovascular health. This situation often leads to polypharmacy, which is the concurrent use of multiple medications by a single individual. While polypharmacy can be necessary for managing complex health conditions, it also poses challenges, including drug interactions, adverse effects and potential impacts on prognosis. In this article, we will explore the prognostic impact of cardiovascular polypharmacy on octogenarians, examining the complexities, potential benefits, and risks associated with managing multiple medications in this vulnerable population. The world's population is experiencing a demographic shift, with a growing proportion of individuals living well into their 80s and beyond.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 